DudeMeds research and fine print
DudeMeds LLC supplies the website, technology, payment, account, and fulfillment coordination layer. The current TRT consent says it is not a medical group and does not employ, supervise, or direct the licensed professionals responsible for care.
The current testosterone consent identifies LocumTele as the independent professional medical entity. Older general telehealth and privacy documents sometimes refer to DudeMeds or the practice as the provider, so the exact clinical entity should be verified for non-TRT products and for the patient's state.
The Terms and Conditions describe DudeMeds LLC as incorporated in Florida. The Terms of Sale describe it as incorporated in Delaware and publish a Wilmington mailing address. This review does not infer a headquarters or choose between those inconsistent legal descriptions.
Most pathways use an asynchronous health questionnaire and clinician review, with live interaction added when required. TRT is materially different: current materials require laboratory testing and a video visit with a clinician licensed in the patient's state.
The service is limited to adults and U.S. delivery. No current product-by-state matrix was located, and access remains subject to professional licensure, prescribing rules, pharmacy shipping capability, product restrictions, and clinical judgment.
After clinical approval, identity verification may use Vouched ID or a government-identification upload. A completed intake does not guarantee a prescription, and a clinician may request more information or decline treatment.
The semaglutide catalog exposes a four-month package at $716 and a separate page labeled as a six-month commitment, Part 1, at $525. The latter page displays $175 monthly but does not reveal the complete six-month charge, so no remaining total is inferred.
The tirzepatide service displays $249 monthly and $747 for three months. It also shows a $1,299 struck-through total without price-history or duration support, so the current payable amount is preserved and the reference anchor is excluded from value claims.
DudeMeds describes the semaglutide and tirzepatide offers as compounded weekly injections from a 503B facility, but it does not publicly name the facility or the patient-specific dispensing pharmacy. Complete formulation, concentration, fill, additives, salt form, and beyond-use date remain order-specific.
The current 12-week TRT selector asks $345 for testosterone cypionate 200 mg/mL and $375 for enclomiphene 12.5 mg capsules. Those charges convert to approximately $125 and $135 per month, materially above the $77 and $125 monthly rates on the main TRT page.
The TRT selector says a laboratory panel is included, and the current consent calls the Commit Kit all-inclusive whether or not medication is prescribed. The general Terms of Sale instead say DudeMeds plays no role in laboratory payment and that the patient is fully responsible. No reviewed page reconciles those clauses.
Testosterone cypionate is shown at 200 mg/mL for intramuscular use. It is a Schedule III controlled substance, and actual dosing, monitoring, refill timing, contraindications, and transfer restrictions depend on the clinician, law, and dispensed label.
The current hCG selection uses branded Pregnyl at $300 for a 10,000 USP unit, 10 mL vial. The provider page says subcutaneous or intramuscular use, while the current Pregnyl label specifies intramuscular administration. The official label controls the card route, and the conflict remains visible.
Dude Chew combines enclomiphene and tadalafil in medicated gum. Another package combines testosterone cypionate with enclomiphene, and a headline combines testosterone with Pregnyl. These packages remain editorial-only because a brand or bundle is not a new active ingredient.
Tadalafil is consolidated into one oral-tablet card. The six-month as-needed package includes 32 tablets at 20 mg for $234, while the daily package includes 180 tablets at 5 mg for $294. The daily page repeats as-needed directions, so patients should use only the clinician's instructions and pharmacy label.
Sildenafil is offered as 48 oral 50 mg tablets over six months for $234. Its reference total of $414 is not used as evidence of savings because the public page does not establish a durable ordinary price or price-history basis.
The selected NAD+ nasal spray service displays 150 mg, $93 monthly, and $279 total without stating a term count. A broader anti-aging page separately says $145 monthly. The review preserves the current selectable monthly label without inferring how many months the total covers.
Clomiphene and Kyzatrex are marked coming soon, the finasteride and minoxidil spray is out of stock, and no exact oral GLP-1 product is exposed in the current new-patient selection. These do not become active comparison cards.
Plans can use monthly, three-month, six-month, nine-month, or annual terms and renew until canceled. DudeMeds says it sends advance notice and charges 72 hours before a refill shipment, so cancellation should be completed before that charge.
The terms say the first three months are due and nonrefundable even if the user suspends or ends service. That obligation materially narrows cancellation-at-any-time messaging and should be confirmed at checkout for the selected package.
A first prescription may be canceled before clinician approval, and DudeMeds says a rejected prescription is not charged. Once a prescription is dispensed, medical products generally cannot be returned or refunded.
Damaged, defective, or incorrect deliveries may qualify for replacement or refund. The terms permit requests for up to two months and say issued refunds generally post in seven to ten business days, but they do not create a broad satisfaction guarantee.
DudeMeds markets free discreet shipping and says approved orders typically ship within 48 hours. Carriers, signatures, weather, shortages, recipient availability, and other events can delay delivery, and no universal arrival date is guaranteed.
DudeMeds lets a patient request a third-party pharmacy, but the platform fees stay unchanged and the patient pays the outside medication, logistics, and insurance costs. The public pages do not name the partner pharmacies used for ordinary fulfillment.
The site says it does not accept insurance and presents HSA or FSA use as possible. Eligibility and reimbursement remain governed by the plan administrator, and the public pages do not guarantee that every DudeMeds charge qualifies.
Support includes the patient portal, care@dudemeds.com for general help, clinic@dudemeds.com for clinical updates, help@dudemeds.com for an unprocessed first order, and 813-444-7995. No response-time or urgent-clinical escalation guarantee is published.
The cookie policy describes analytics, retargeting, behavioral advertising, and association of visits or logins with personal information through vendors. Protected clinical information may be governed separately, but ordinary site and advertising data should not be assumed to have identical restrictions.
The privacy policy includes older framework language and broad vendor disclosures. The HIPAA notice describes treatment, payment, operations, business associates, research, fundraising, marketing rules, and patient rights, while the telehealth consent permits electronic communications and possible recording.
DudeMeds calls compounded semaglutide and tirzepatide generic forms and sometimes places FDA-approved language near compounded products. FDA states that compounded drugs are not FDA approved and should not be presented as generic, the same as, or equivalent to an approved medicine.
FDA guidance also warns that compounded GLP-1 products are not reviewed for safety, effectiveness, or quality before marketing and identifies dosing, salt-form, refrigeration, and sourcing concerns. Patients should verify the exact prescription and licensed dispensing pharmacy.
The site presents a LegitScript seal and broad award and media claims. The public checker did not provide a readable independent result during this research, and no current linked support established the broad Best TRT or publication claims, so they remain provider-presented signals.
DudeMeds terms restrict outside links that mention specific medications. Because the affiliate relationship is still pending, AllyRx must confirm Katalys approval and advertiser linking rules before replacing the canonical CTA with any tracking URL.
- Eight cards preserve real ingredient-and-route distinctions while branded combinations and unavailable products remain narrative-only.
- Current checkout totals are more useful than headlines, but several do not reconcile with the advertised monthly rates.
- TRT has a defined labs-plus-video workflow, yet the general terms assign laboratory payment to the patient.
- The current TRT consent names LocumTele; older documents describe provider roles less precisely.
- Plans renew automatically, charges occur before shipment, and the first three months may remain due.
- Partner pharmacies and complete treatment-by-state availability are not public before intake.
- Product pages contain material route, directions, and compounded-drug description conflicts.
- Privacy materials permit analytics, retargeting, and vendor data association beyond protected clinical records.
